Sofinnova Ventures Inc Buys Alexion Pharmaceuticals Inc, Merck Inc, Align Technology Inc, Sells Regeneron Pharmaceuticals Inc, Biomarin Pharmaceutical Inc, Mirati Therapeutics Inc

• New Purchases: ALXN, ALGN, PBYI, AXSM, ABBV, BPMC, AGTC, AKRO, CGEN, RIGL, SAGE, MNLO, MRSN, ZGNX, ITCI,
• Added Positions: MRK, HRTX, UTHR, KALA, FIXX, XLRN, SRPT, FOLD,
• Reduced Positions: BMRN, CCXI, VRTX, FATE, PTCT, TGTX, BCRX, KDMN, CALA, BIIB, ZYME, MYOK,
• Sold Out: REGN, MRTX, MGNX, DERM, ARQL, SGEN, FTSV, XBIT, FOMX, ORTX, DRNA, HALO, RYTM,

For the details of Sofinnova Ventures Inc's stock buys and sells, go to https://www.gurufocus.com/guru/sofinnova+ventures+inc/current-portfolio/portfolio

1. Karuna Therapeutics Inc (KRTX) - 1,885,602 shares, 13.51% of the total portfolio.
2. Ascendis Pharma A/S (ASND) - 1,109,874 shares, 12.43% of the total portfolio.
3. NextCure Inc (NXTC) - 2,671,856 shares, 9.85% of the total portfolio.
4. Natera Inc (NTRA) - 3,100,560 shares, 9.21% of the total portfolio.
5. Principia Biopharma Inc (PRNB) - 1,417,258 shares, 8.37% of the total portfolio.

Sofinnova Ventures Inc initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $75.56 and $113.92, with an estimated average price of $98.6. The stock is now traded at around $101.65. The impact to a portfolio due to this purchase was 2.75%. The holding were 307,300 shares as of .

Sofinnova Ventures Inc initiated holding in Align Technology Inc. The purchase prices were between $137.72 and $298.07, with an estimated average price of $241.25. The stock is now traded at around $206.45. The impact to a portfolio due to this purchase was 0.8%. The holding were 46,500 shares as of .

Sofinnova Ventures Inc initiated holding in Puma Biotechnology Inc. The purchase prices were between $6.28 and $14.57, with an estimated average price of $9.74. The stock is now traded at around $12.29. The impact to a portfolio due to this purchase was 0.54%. The holding were 638,026 shares as of .

Sofinnova Ventures Inc initiated holding in Axsome Therapeutics Inc. The purchase prices were between $41.2 and $103.36, with an estimated average price of $82.09. The stock is now traded at around $89.58. The impact to a portfolio due to this purchase was 0.43%. The holding were 73,163 shares as of .

Sofinnova Ventures Inc initiated holding in AbbVie Inc. The purchase prices were between $64.5 and $97.79, with an estimated average price of $85.41. The stock is now traded at around $90.46. The impact to a portfolio due to this purchase was 0.38%. The holding were 50,000 shares as of .

Sofinnova Ventures Inc initiated holding in Blueprint Medicines Corp. The purchase prices were between $48.11 and $82.22, with an estimated average price of $64.89. The stock is now traded at around $63.33. The impact to a portfolio due to this purchase was 0.37%. The holding were 63,100 shares as of .

Sofinnova Ventures Inc added to a holding in Merck & Co Inc by 92.60%. The purchase prices were between $66.4 and $92.04, with an estimated average price of $82.63. The stock is now traded at around $77.19. The impact to a portfolio due to this purchase was 1.71%. The holding were 463,795 shares as of .

Sofinnova Ventures Inc added to a holding in Heron Therapeutics Inc by 853.68%. The purchase prices were between $10.23 and $24.53, with an estimated average price of $18.95. The stock is now traded at around $14.67. The impact to a portfolio due to this purchase was 0.5%. The holding were 481,608 shares as of .

Sofinnova Ventures Inc added to a holding in United Therapeutics Corp by 23.81%. The purchase prices were between $79.39 and $115.35, with an estimated average price of $95.05. The stock is now traded at around $114.25. The impact to a portfolio due to this purchase was 0.42%. The holding were 233,559 shares as of .

Sofinnova Ventures Inc added to a holding in Kala Pharmaceuticals Inc by 67.69%. The purchase prices were between $3.69 and $8.79, with an estimated average price of $6.36. The stock is now traded at around $11.95. The impact to a portfolio due to this purchase was 0.39%. The holding were 1,114,520 shares as of .

Sofinnova Ventures Inc added to a holding in Homology Medicines Inc by 258.19%. The purchase prices were between $12.5 and $22.04, with an estimated average price of $17.1. The stock is now traded at around $13.66. The impact to a portfolio due to this purchase was 0.26%. The holding were 230,663 shares as of .

Sofinnova Ventures Inc sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $336.18 and $494.43, with an estimated average price of $411.31.

Sofinnova Ventures Inc sold out a holding in Mirati Therapeutics Inc. The sale prices were between $69.78 and $128.86, with an estimated average price of $90.44.

Sofinnova Ventures Inc sold out a holding in Macrogenics Inc. The sale prices were between $4.28 and $12.11, with an estimated average price of $9.16.

Sofinnova Ventures Inc sold out a holding in Dermira Inc. The sale prices were between $14.65 and $19.19, with an estimated average price of $18.32.

Sofinnova Ventures Inc sold out a holding in Arqule Inc. The sale prices were between $19.96 and $20.04, with an estimated average price of $20.

Sofinnova Ventures Inc sold out a holding in Seattle Genetics Inc. The sale prices were between $95.75 and $119.97, with an estimated average price of $110.87.